Clinical and spectroscopic improvement in HIV-associated cognitive impairment

被引：55
|
作者：
Stankoff, B
Tourbah, A
Suarez, S
Turell, E
Stievenart, JL
Payan, C
Coutellier, A
Herson, S
Baril, L
Bricaire, F
Calvez, V
Cabanis, EA
Lacomblez, L
Lubetzki, C
机构：
[1] Hop La Pitie Salpetriere, APHP, Federat Neurol 1, F-75651 Paris 13, France
[2] Hop La Pitie Salpetriere, APHP, Lab Neuropathol R Escourolle, F-75651 Paris 13, France
[3] Hop La Pitie Salpetriere, APHP, Federat Neurol 2, F-75651 Paris 13, France
[4] Hop La Pitie Salpetriere, APHP, Serv Pharmacol, F-75651 Paris 13, France
[5] Hop La Pitie Salpetriere, APHP, Serv Med Interne, F-75651 Paris 13, France
[6] Hop La Pitie Salpetriere, APHP, Serv Malad Infect, F-75651 Paris 13, France
[7] Hop La Pitie Salpetriere, APHP, Lab Virol CERVI, F-75651 Paris 13, France
[8] Univ Paris 06, Paris, France
[9] Ctr Hosp natl Quinze Vingts, Serv Neuroradiol, Paris, France
来源：
NEUROLOGY | 2001年 / 56卷 / 01期
关键词：
D O I：
10.1212/WNL.56.1.112
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
To assess the impact of highly active antiretroviral therapy (HAART) on AIDS-associated cognitive impairment, 22 patients with AIDS with (n = 11) and without (n = 11) cognitive deficit were evaluated clinically and by MRS every 3 months for 9 months. Nineteen patients were on HAART at study entry, 21 after 2 months. Cognitively impaired patients presented with a subcorticofrontal deficit and decreased N-acetyl-aspartate in frontal white matter. These clinical and metabolic abnormalities reversed partially on HAART, whereas they remained within normal limits in cognitively unimpaired patients.
引用
收藏
页码：112 / 115
页数：4
相关论文
共 50 条
  • [31] Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment
    Kieburtz, K
    Schifitto, G
    McDermott, M
    Heo, M
    Irvine, C
    Palumbo, D
    Orme, C
    Zimmerman, C
    Gelbard, H
    Hickey, C
    Casaceli, C
    Guthrie, B
    Rumfola, L
    Epstein, L
    Marder, K
    Ramachandran, G
    Albert, S
    Dooneief, G
    Stern, Y
    Todak, G
    FriedmanClouse, R
    Polanco, C
    Winston, T
    Mayeux, R
    DalPan, G
    Selnes, O
    Sacktor, N
    Hasenauer, D
    Esposito, D
    NanceSproson, L
    McArthur, JC
    Shoulson, I
    Oakes, D
    Reichman, R
    OSullivan, J
    NEUROLOGY, 1997, 49 (01) : 142 - 146
  • [32] HIV-Associated Cognitive Impairment in Perinatally Infected Children: A Meta-analysis
    Phillips, Nicole
    Amos, Taryn
    Kuo, Caroline
    Hoare, Jacqueline
    Ipser, Jonathan
    Thomas, Kevin G. F.
    Stein, Dan J.
    PEDIATRICS, 2016, 138 (05)
  • [33] Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report
    Schifitto, G
    Peterson, DR
    Zhong, J
    Ni, H
    Cruttenden, K
    Gaugh, M
    Gendelman, HE
    Boska, M
    Gelbard, H
    NEUROLOGY, 2006, 66 (06) : 919 - 921
  • [34] Minocycline treatment for HIV-associated cognitive impairment Results from a randomized trial
    Sacktor, N.
    Miyahara, S.
    Deng, L.
    Evans, S.
    Schifitto, G.
    Cohen, B. A.
    Paul, R.
    Robertson, K.
    Jarocki, B.
    Scarsi, K.
    Coombs, R. W.
    Zink, M. C.
    Nath, A.
    Smith, E.
    Ellis, R. J.
    Singer, E.
    Weihe, J.
    McCarthy, S.
    Hosey, L.
    Clifford, D. B.
    NEUROLOGY, 2011, 77 (12) : 1135 - 1142
  • [35] Lithium improves HIV-associated neurocognitive impairment
    Letendre, Scott L.
    Woods, Steven P.
    Ellis, Ronald J.
    Atkinson, J. Hampton
    Masliah, Eliezer
    van den Brande, Geoffrey
    Durelle, Janis
    Grant, Igor
    Everall, Ian
    AIDS, 2006, 20 (14) : 1885 - 1888
  • [36] Functional Consequences of HIV-Associated Neuropsychological Impairment
    Ashley A. Gorman
    Jessica M. Foley
    Mark L. Ettenhofer
    Charles H. Hinkin
    Wilfred G. van Gorp
    Neuropsychology Review, 2009, 19 : 186 - 203
  • [37] Functional Consequences of HIV-Associated Neuropsychological Impairment
    Gorman, Ashley A.
    Foley, Jessica M.
    Ettenhofer, Mark L.
    Hinkin, Charles H.
    van Gorp, Wilfred G.
    NEUROPSYCHOLOGY REVIEW, 2009, 19 (02) : 186 - 203
  • [38] Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study
    Schifitto, Giovanni
    Navia, Bradford A.
    Yiannoutsos, Constantin T.
    Marra, Christina M.
    Chang, Linda
    Ernst, Thomas
    Jarvik, Jeffrey G.
    Miller, Eric N.
    Singerg, Elyse J.
    Ellis, Ronald J.
    Kolson, Dennis L.
    Simpson, David
    Nath, Avindra
    Berger, Joseph
    Shriver, Sharon L.
    Millar, Linda L.
    Colquhoun, Dodi
    Lenkinski, Robert
    Gonzalez, R. Gilberto
    Liptonq, Stuart A.
    AIDS, 2007, 21 (14) : 1877 - 1886
  • [39] A comparison of two magnetic resonance spectroscopy techniques in individuals with HIV-associated cognitive impairment
    Sacktor, NC
    Bobo, L
    Skolasky, RL
    Pomper, MG
    Ernst, T
    Chang, L
    Zhong, K
    Shungu, DC
    Marder, K
    Mao, XL
    Shibata, D
    Schifitto, G
    Barker, PB
    NEUROLOGY, 2001, 56 (08) : A474 - A474
  • [40] Does Antiretroviral Therapy Improve HIV-Associated Cognitive Impairment? A Quantitative Review of the Literature
    Al-Khindi, Timour
    Zakzanis, Konstantine K.
    van Gorp, Wilfred G.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2011, 17 (06) : 956 - 969
12345